Cyclooxygenase inhibitors--current status and future prospects.
about
Effects of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicansOverview of Antagonists Used for Determining the Mechanisms of Action Employed by Potential Vasodilators with Their Suggested Signaling PathwaysNon steroidal anti-inflammatory drugs and COX-2 inhibitors as anti-cancer therapeutics: hypes, hopes and realityAnti-inflammatory pharmacotherapy during pregnancyA free energy based computational pathway from chemical templates to lead compounds: a case study of COX-2 inhibitorsCongenital ventricular septal defects and prenatal exposure to cyclooxygenase inhibitorsA novel electron paramagnetic resonance-based assay for prostaglandin H synthase-1 activityReactive oxygen species-activated nanoprodrug of Ibuprofen for targeting traumatic brain injury in miceDiverse methyl sulfone-containing benzo[b]thiophene library via iodocyclization and palladium-catalyzed coupling.Protective effect of Shenmai injection on knee articular cartilage of osteoarthritic rabbits and IL-1β-stimulated human chondrocytesIn vivo and in vitro anti-inflammatory activity of Cryptostegia grandiflora Roxb. ex R. Br. leaves.Complications of umbilical artery catheterization in a model of extreme prematurity.5-(4-tert-Butyl-benzyl-sulfan-yl)-3-methyl-1-phenyl-1H-pyrazole-4-carbaldehydeDoes administration of non-steroidal anti-inflammatory drug determine morphological changes in adrenal cortex: ultrastructural studiesInsights into the slow-onset tight-binding inhibition of Escherichia coli dihydrofolate reductase: detailed mechanistic characterization of pyrrolo [3,2-f] quinazoline-1,3-diamine and its derivatives as novel tight-binding inhibitors.Reovirus cell entry requires functional microtubules.Medicinal chemistry approaches for the treatment and prevention of Alzheimer's disease.Global impairment and therapeutic restoration of visual plasticity mechanisms after a localized cortical stroke.Sclareol exerts anti-osteoarthritic activities in interleukin-1β-induced rabbit chondrocytes and a rabbit osteoarthritis model.Synthesis and structure-activity relationship studies of urea-containing pyrazoles as dual inhibitors of cyclooxygenase-2 and soluble epoxide hydrolaseCOX-2 and its inhibition as a molecular target in the prevention and treatment of lung cancer.Synthesis and evaluation of antiinflammatory, analgesic and ulcerogenic potential of NSAIDs bearing 1,3,4-oxadiazole scaffold.Analgesic and Toxicity Studies of Aminoacetylenic Isoindoline-1,3-dione Derivatives.PPARγ activation prevents impairments in spatial memory and neurogenesis following transient illnessComparison of parecoxib and proparacetamol in endoscopic nasal surgery patients.Synthesis and quantitative structure-activity relationship study of substituted imidazophosphor ester based tetrazolo[1,5-b]pyridazines as antinociceptive/anti-inflammatory agents.Role of peroxisome proliferator-activated receptor alpha in the control of cyclooxygenase 2 and vascular endothelial growth factor: involvement in tumor growth.Parecoxib has non-significant long-term effects on bone healing in rats when administered for a short period after fracture.Synthesis and investigations of double-pharmacophore ligands for treatment of chronic and neuropathic pain.Dietary resveratrol improves immunity but reduces reproduction of broodstock medaka Oryzias latipes (Temminck & Schlegel).Synthesis, characterization and pharmacological evaluation of pyrazolyl urea derivatives as potential anti-inflammatory agents.Toxicity and biodegradation of ibuprofen by Bacillus thuringiensis B1(2015b).COX-2 inhibition and pain management: a review summary.Eicosanoids in inflammation and cancer: the role of COX-2.Database survey of anti-inflammatory plants in South America: a review.Selective COX-2 Inhibitors: A Review of Their Structure-Activity Relationships.Lead optimization on conventional non-steroidal anti-inflammatory drugs: an approach to reduce gastrointestinal toxicity.Inhibitors of microsomal prostaglandin E2 synthase-1 enzyme as emerging anti-inflammatory candidates.Non-steroidal anti-inflammatory drug use in chronic pain conditions with special emphasis on the elderly and patients with relevant comorbidities: management and mitigation of risks and adverse effects.Recent advances in the chemistry and biology of benzothiazoles.
P2860
Q24630887-222B5BE5-99E4-4E8C-8020-57C6911FAED2Q26752401-175509B8-8140-49DD-BD2E-902615BB034BQ28166312-3AF57F05-C7A4-469F-9356-1C56C915575BQ28167716-BBDAF691-74DF-42FE-9921-304D01C5796AQ28168392-F4D4E099-256B-420D-A98B-0591983D0419Q28199711-FA4007EA-5E9A-4521-8AEC-CF2C4207F092Q28200568-69ECA8AC-290F-4E24-B72F-C339A51DF4CDQ28486825-C8756B7F-68A6-4343-B4AC-A91CD3B4D6D9Q33522431-3C218B10-04D3-4F49-A37D-88B00F45EEEAQ33744824-6CF4545B-AC0B-4955-B43D-26360C7B3DA5Q33984657-C9C1B794-9250-4510-9D1E-2AA95C826D67Q33999988-5F991671-0E4F-48C0-9E1D-EB06BEA14EF8Q34041110-774B1B30-E5AD-4D02-857D-2DCD90EDFB8BQ34161193-D43E47B6-4255-4EEC-9080-6D0F50DDE7BAQ34463959-BBF6C441-EF20-47AC-95EB-378004860628Q34790998-A64A97CF-3EFA-4EF0-8AFC-B39CCF2E066CQ34993154-BAFF57A1-9C42-48F9-9A2E-576FF6067B8FQ35216996-74BED1BF-C5E2-4091-BEA6-076D88F0F7A0Q35632005-86F17ABE-10D9-4991-A1ED-293023DC6B79Q35762636-0F5CBEB8-2FE3-44C5-95B1-13E8D98BC5FFQ35843673-64F84256-1BA2-4D37-80A2-8C7DA600A8B5Q36345994-0328E32E-5F0C-461F-A311-783321ABF2A1Q36516027-7BA68C14-545C-4BBD-B025-E64BFD997FE7Q36605328-340A848A-B808-4393-A4E0-D42E71E9BA24Q37041111-75F983DD-80FE-4FD9-9166-743992AE5155Q37185968-96394302-1765-4D77-A6DB-CEB5D0088FEBQ37231752-47FA39F2-766F-4434-8C15-34E043009533Q37313416-FA7C2D6E-3BEE-4418-9823-6FB734164054Q37381216-642749B4-36D9-40E4-BB9A-70FE039B4823Q37639585-040A7225-E2A4-4C91-8591-19C24068E669Q37689630-372BFAC6-5CE6-4A0D-8E06-ED8EBFCD485CQ37740603-01F0A4EF-77DA-498F-A6DE-D20F06878001Q37754624-81230834-8E93-4B1A-981B-3DB20DF9ADB2Q37754720-E6339B6E-2DCC-4F00-AA04-7DC8A3C1768EQ37897964-3B279223-62BB-424E-9A51-A77D67BA895FQ38163980-DB664125-33DD-4802-A97B-4C5E2D37E625Q38181591-3863C949-A3CB-4288-9B1D-0BF6937732CDQ38229056-08AB3646-B3EB-40EA-8F47-5305E4E0F0ADQ38243967-DFA6DA49-54B3-4866-9482-7AE316E3B7A6Q38355999-1C1BEF29-ADC6-4186-8DFE-F11193707F7A
P2860
Cyclooxygenase inhibitors--current status and future prospects.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Cyclooxygenase inhibitors--current status and future prospects.
@ast
Cyclooxygenase inhibitors--current status and future prospects.
@en
type
label
Cyclooxygenase inhibitors--current status and future prospects.
@ast
Cyclooxygenase inhibitors--current status and future prospects.
@en
prefLabel
Cyclooxygenase inhibitors--current status and future prospects.
@ast
Cyclooxygenase inhibitors--current status and future prospects.
@en
P1476
Cyclooxygenase inhibitors--current status and future prospects.
@en
P2093
P304
P356
10.1016/S0223-5234(01)01197-7
P577
2001-02-01T00:00:00Z